scutellarin has been researched along with Ischemic Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, X; Liang, Y; Liu, G; Song, W; Sun, M; Sun, W; Wang, Z; Xu, M; Zhou, Y | 1 |
| Fu, CG; Guo, SY; Liu, SY; Liu, XK; Meng, ZQ; Ni, MW; Wu, JR; Zhou, W; Zhu, YL | 1 |
2 other study(ies) available for scutellarin and Ischemic Stroke
| Article | Year |
|---|---|
Protective mechanism of Erigeron breviscapus injection on blood-brain barrier injury induced by cerebral ischemia in rats.
Topics: Animals; Apigenin; Blood-Brain Barrier; Chlorogenic Acid; Drugs, Chinese Herbal; Erigeron; Glucuronates; Ischemic Stroke; Male; Matrix Metalloproteinase 9; Nitric Oxide Synthase Type II; Occludin; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Zonula Occludens-1 Protein | 2021 |
Revealing the Common Mechanisms of Scutellarin in Angina Pectoris and Ischemic Stroke Treatment via a Network Pharmacology Approach.
Topics: Angina Pectoris; Apigenin; Brain Ischemia; Glucuronates; Humans; Ischemic Stroke; Molecular Docking Simulation; Phosphatidylinositol 3-Kinases | 2021 |